Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Helen Phillips
Observed name:
Phillips, Helen
Institution:
Chiesi (Italy)
Observed institutions:
German Centre for Integrative Biodiversity Research,
NYU Langone Health,
Bexion Pharmaceuticals (United States),
Acacia Pharma (United Kingdom),
Chiesi (Italy),
Cyclerion (United States),
Leipzig University
show all 7
ORCID:
0000-0002-4406-4394
Observed ORCID:
0000-0002-4406-4394
OpenAlex ID:
A5089045688
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
2020
·
James A. Underberg
, Christopher P. Cannon
, et al.
·
Journal of clinical lipidology
·
75
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
2018
·
Dirk J. Blom
, Marina Cuchel
, et al.
·
Orphanet Journal of Rare Diseases
·
43
PDF
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
2017
·
Robert Leipold
, Frederick Raal
, et al.
·
European Journal of Preventive Cardiology
·
37
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey
2024
·
Nivedita Patni
, Craig Chard
, et al.
·
Orphanet Journal of Rare Diseases
·
12
PDF
Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy
2025
·
Rebecca J Brown
, Baris Akinci
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
9
Lomitapide Observational Worldwide Evaluation Registry (LOWER): One-Year Data†
2016
·
James Underberg
, Dominique Larrey
, et al.
·
Journal of clinical lipidology
·
6
Abstract 10818: Lomitapide Observational Worldwide Evaluation Registry (LOWER): One-Year Data
2015
·
Dirk Blom
, John J Kastelein
, et al.
·
Circulation
·
6
Abstract 12117: Global Real-World Data on the Use of Lomitapide in Treating Homozygous Familial Hypercholesterolemia: The Lomitapide Observational Worldwide Evaluation Registry (LOWER), Two-Year Data
2016
·
James Underberg
, Christopher Cannon
, et al.
·
Circulation
·
3
Long-term Safety and Efficacy of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia: Five-year Data From the Lomitapide Observational Worldwide Evaluation Registry (lower)
2020
·
James A. Underberg
, Christopher P. Cannon
, et al.
·
Journal of the American College of Cardiology
·
2
PDF
Show more works
View as search
Works count:
11
Citation count:
193
H-index:
6
I10-index:
4
Year
Topic
Type
